Smoking-related idiopathic interstitial pneumonia: A review

Respirology

Volumn 21, Issue 1, 2016, Pages 57-64

  Margaritopoulos, George A ^a,b   Harari, Sergio ^c   Caminati, Antonella ^c   Antoniou, Katerina M ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b General Hospital of Kavala   (Greece)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

diagnosis; fibrosis; inflammation; nicotine; smoking; therapy

Indexed keywords

COLLAGEN; GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; DESQUAMATIVE INTERSTITIAL PNEUMONIA; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LANGERHANS CELL HISTIOCYTOSIS; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG HEMORRHAGE; LUNG INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY BRONCHIOLITIS INTERSTITIAL LUNG DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SMOKING HABIT; ADVERSE EFFECTS; BRONCHIOLITIS; EMPHYSEMA; GENETIC DISEASES, INBORN; HISTIOCYTOSIS, LANGERHANS-CELL; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG DISEASES, INTERSTITIAL; PULMONARY EMPHYSEMA; SMOKING;

BRONCHIOLITIS; EMPHYSEMA; GENETIC DISEASES, INBORN; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG DISEASES, INTERSTITIAL; PULMONARY EMPHYSEMA; SMOKING;

EID: 84952870639     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12576     Document Type: Review

References (90)

1. Houghton AM, Mouded M, Shapiro SD,. Common origins of lung cancer and COPD. Nat. Med. 2008; 14: 1023-1024.
2. Wells AU, Nicholson AG, Hansell DM,. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax 2007; 62: 904-910.
3. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA,. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997; 155: 242-248.
4. Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM, Wells AU,. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am. J. Respir. Crit. Care Med. 2008; 177: 190-194.
5. Colby TV, Lombard C,. Histiocytosis X in the lung. Hum. Pathol. 1983; 14: 847-856.
6. Travis WD, Borok Z, Roum JH, Zhang J, Feuerstein I, Ferrans VJ, Crystal RG,. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am. J. Surg. Pathol. 1993; 17: 971-986.
7. Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL,. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993; 186: 643-651.
8. Tomita K, Caramori G, Lim S, Ito K, Hanazawa T, Oates T, Chiselita I, Jazrawi E, Chung KF, Barnes PJ, et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am. J. Respir. Crit. Care Med. 2002; 166: 724-731.
9. Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P,. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996; 51: 611-614.
10. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P,. Evidence that granulocyte macrophage-colony stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J. Clin. Invest. 1993; 91: 566-576.
11. Wang RD, Wright JL, Churg A,. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am. J. Respir. Cell Mol. Biol. 2005; 33: 387-393.
12. Margaritopoulos GA, Romagnoli M, Poletti V, Siafakas NM, Wells AU, Antoniou KM,. Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis. Eur Respir Rev. 2012; 21: 48-56.
13. Jensen K, Nizamutdinov D, Guerrier M, Afroze S, Dostal D, Glaser S,. General mechanisms of nicotine-induced fibrogenesis. FASEB J. 2012; 26: 4778-4787.
14. Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí AG,. Telomere shortening in smokers with and without COPD. Eur. Respir. J. 2006; 27: 525-528.
15. Huzen J, Wong LS, van Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, Cawthon RM, Benus GF, van der Horst IC, Navis G, et al. Telomere length loss due to smoking and metabolic traits. J. Intern. Med. 2014; 275: 155-163.
16. Chilosi M, Poletti V, Rossi A,. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir. Res. 2012; 13: 3.
17. Armanios M,. Syndromes of telomere shortening. Annu. Rev. Genomics Hum. Genet. 2009; 10: 45-61.
18. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA. 2008; 105: 13051-13056.
19. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK,. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729-737.
20. Margaritopoulos GA, Tsitoura E, Tzanakis N, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM,. Self-eating: friend or foe? The emerging role of autophagy in idiopathic pulmonary fibrosis. Biomed Res Int. 2013; 2013: 420497.
21. Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO, Morse D,. Autophagy in idiopathic pulmonary fibrosis. PLoS ONE 2012; 7: e41394.
22. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An Official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733-748.
23. Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ,. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 2008; 28: 1383-1396.
24. Caminati A, Graziano P, Sverzellati N, Harari S,. Smoking-related interstitial lung diseases. Pathologica 2010; 102: 525-536.
25. Aubry MC, Wright JL, Myers JL,. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11-35.
26. Ryu JH, Colby TV, Hartman TE, Vassallo R,. Smoking-related interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122-132.
27. Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE, Limper AH,. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199-1205.
28. Nair A, Hansell DM,. High-resolution computed tomography features of smoking-related interstitial lung disease. Semin Ultrasound CT MRI 2014; 35: 59-71.
29. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
30. Fraig M, Shreesha U, Savici D, Katzenstein AL,. Respiratory bronchiolitis: a clinic-pathologic study in current smokers, ex-smokers, and never- smokers. Am. J. Surg. Pathol. 2002; 26: 647-653.
31. Park JS, Brown KK, Tuder RM, Hale VA, King TE Jr, Lynch DA,. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J. Comput. Assist. Tomogr. 2002; 26: 13-20.
32. Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA,. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005; 127: 178-184.
33. Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack RM, King TE Jr, Brown KK,. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007; 131: 664-671.
34. Hansell DM, Nicholson AG,. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin. Respir. Crit. Care Med. 2003; 24: 377-392.
35. Craig PJ, Wells AU, Doffman S, Rassl D, Colby TV, Hansell DM, Du Bois RM, Nicholson AG,. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275-282.
36. Tazelaar HD, Wright JL, Churg A,. Desquamative interstitial pneumonia. Histopathology 2011; 58: 509-516.
37. Caminati A, Cavazza A, Sverzellati N, Harari S,. An integrated approach in diagnosis of smoking-related interstitial lung diseases. Eur Respir Rev 2012; 21: 207-217.
38. Bone RC, Wolfe J, Sobonya RE, Kerby GR, Stechschulte D, Ruth WE, Welch M,. Desquamative interstitial pneumonia following long-term nitrofurantoin therapy. Am. J. Med. 1976; 60: 697-701.
39. Abraham JL, Hertzberg MA,. Inorganic particulates associated with desquamative interstitial pneumonia. Chest 1981; 80: 67-70.
40. Herbert A, Sterling G, Abraham J, Corrin B,. Desquamative interstitial pneumonia in an aluminum welder. Hum. Pathol. 1982; 13: 694-699.
41. Hamadeh MA, Atkinson J, Smith LJ,. Sulfasalazine-induced pulmonary disease. Chest 1992; 101: 1033-1037.
42. Katzenstein A-LA, Myers JL,. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 1998; 157: 1301-1315.
43. Amir G, Ron N,. Pulmonary pathology in Gaucher's disease. Hum. Pathol. 1999; 30: 666-670.
44. Rao RN, Goodman LR, Tomashefski JF,. Smoking-related interstitial lung disease. Ann. Diagn. Pathol. 2008; 12: 445-457.
45. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, Sockrider MM, Fan LL,. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366-373.
46. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM,. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026-1031.
47. Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Müller NL,. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993; 187: 787-790.
48. Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E,. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997; 52: 333-337.
49. Desai SR, Ryan SM, Colby TV,. Smoking-related interstitial lung diseases: histopathological and imaging perspectives. Clin. Radiol. 2003; 58: 259-268.
50. Johkoh T, Müller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M, Ichikado K, Ando M, Nakamura H,. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555-560.
51. Hartman TE, Primack SL, Kang E-Y, Swensen SJ, Hansell DM, McGuinness G, Müller NL,. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia: assessment with serial CT. Chest 1996; 110: 378-382.
52. Katzenstein A-LA,. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J. Clin. Pathol. 2013; 66: 882-887.
53. Katzenstein A-LA, Mukhopadhyay S, Zanardi C, Dexter E,. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316-325.
54. Yousem SA,. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod. Pathol. 2006; 19: 1474-1479.
55. Kawabata Y, Hoshi E, Murai K, Ikeya T, Takahashi N, Saitou Y, Kurashima K, Ubukata M, Takayanagi N, Sugita H, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707-714.
56. Reddy TL, Mayo J, Churg A,. Respiratory bronchiolitis with fibrosis: high resolution computed tomography findings and correlation with pathology. Ann Am Thorac Soc. 2013; 10: 590-601.
57. Katzenstein A-LA,. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod. Pathol. 2012; 25: S68-78.
58. Churg A, Hall R, Bilawich AM,. Respiratory bronchiolitis with fibrosis-interstitial lung disease. A new form of smoking-induced interstitial lung disease. Arch. Pathol. Lab. Med. 2015; 139: 437-440.
59. Katzenstein A-LA,. Surgical Pathology of Non-Neoplastic Lung Disease. Elsevier-Saunders, Philadelphia, PA, 2006.
60. Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, et al. Idiopathic nonspecific interstitial pneumonia. Report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338-1347.
61. Sverzellati N, Guerci L, Giorgia R, Calabrò E, La Vecchia C, Marchianò A, Pesci A, Zompatori M, Pastorino U,. Interstitial lung diseases in a lung cancer screening trial. Eur. Respir. J. 2011; 38: 392-400.
62. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estépar RS, Lynch DA, Brehm JM, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N. Engl. J. Med. 2011; 364: 897-906.
63. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-593.
64. Cottin V, Fabien N, Khouatra C, Moreira A, Cordier JF,. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur. Respir. J. 2009; 33: 219-221.
65. Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, Cordier JF, GERM'O'P. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105-111.
66. Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M,. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
67. Girard N, Marchand-Adam S, Naccache JM, Borie R, Urban T, Jouneau S, Marchand E, Ravel AC, Kiakouama L, Etienne-Mastroianni B, et al. Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. J Thorac Oncol 2014; 9: 1162-1170.
68. Samara KD, Margaritopoulos G, Wells AU, Siafakas NM, Antoniou KM,. Smoking and pulmonary fibrosis: novel insights. Pulm Med. 2011; 2011: 461439.
69. Antoniou KM, Walsh SL, Hansell DM, Rubens MR, Marten K, Tennant R, Hansel T, Desai SR, Siafakas NM, du Bois RM, et al. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology 2013; 18: 1191-1196.
70. Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, Revel D, Valeyre D, Cordier JF, Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011; 63: 295-304.
71. Margaritopoulos GA, Antoniou KM, Hansell D, Rubens M, Desai S, Siafakas NM, Wells AU,. The role of smoking in the pathogenesis of systemic sclerosis associated lung fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: A6607.
72. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH,. Pulmonary Langerhans'-cell histiocytosis. N. Engl. J. Med. 2000; 342: 1969-1978.
73. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH,. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N. Engl. J. Med. 2002; 346: 484-490.
74. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr,. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am. J. Respir. Crit. Care Med. 1996; 153: 426-435.
75. Harari S, Brenot F, Barberis M, Simmoneau G,. Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension. Chest 1997; 111: 1142-1144.
76. Soler P, Chollet S, Jacque C, Fukuda Y, Ferrans VJ, Basset F,. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am. J. Pathol. 1985; 118: 439-451.
77. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F,. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am. J. Pathol. 1984; 115: 225-232.
78. Harari S, Torre O, Cassandro R, Taveira-DaSilva AM, Moss J,. Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis. Respir. Med. 2012; 106: 1286-1292.
79. Suri HS, Yi ES, Nowakowski GS, Vassallo R,. Pulmonary Langerhans cell histiocytosis. Orphanet J. Rare Dis. 2012; 7: 16.
80. Chaowalit N, Pellikka PA, Decker PA, Aubry MC, Krowka MJ, Ryu JH, Vassallo R,. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin. Proc. 2004; 79: 1269-1275.
81. Aerni MR, Aubry MC, Myers JL, Vassallo R,. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir. Med. 2008; 102: 316-319.
82. Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF,. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax 2009; 64: 274-275.
83. Grobost V, Khouatra C, Lazor R, Cordier JF, Cottin V,. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis. Orphanet J. Rare Dis. 2014; 9: 191.
84. Dauriat G, Mal H, Thabut G, Mornex JF, Bertocchi M, Tronc F, Leroy-Ladurie F, Dartevelle P, Reynaud-Gaubert M, Thomas P, et al. Lung transplantation for pulmonary Langerhans cell histiocytosis: a multicenter analysis. Transplantation 2006; 81: 746-750.
85. Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH,. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125: 1028-1032.
86. Kiakouama L, Cottin V, Etienne-Mastroianni B, Khouatra C, Humbert M, Cordier JF,. Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan. Eur. Respir. J. 2010; 36: 202-204.
87. Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS,. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013; 268: 563-571.
88. Cordier JF, Cottin V, Khouatra C, Revel D,. Screening for lung cancer and idiopathic pulmonary fibrosis: killing two birds with one stone. Radiology 2014; 270: 630-631.
89. Antoniou KM, Symvoulakis EK, Margaritopoulos GA, Lionis C, Wells AU,. Early diagnosis of IPF: time for a primary-care case-finding initiative? Lancet Respir Med. 2014; 2: e1.
90. Flaherty KR, Fell C, Aubry MC, Brown K, Colby T, Costabel U, Franks TJ, Gross BH, Hansell DM, Kazerooni E, et al. Smoking-related idiopathic interstitial pneumonia. Eur. Respir. J. 2014; 44: 594-602.